Cargando…

Current Landscape of Heart Failure Gene Therapy

Detalles Bibliográficos
Autores principales:	Kieserman, Jake M., Myers, Valerie D., Dubey, Praveen, Cheung, Joseph Y., Feldman, Arthur M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585330/ https://www.ncbi.nlm.nih.gov/pubmed/31070089 http://dx.doi.org/10.1161/JAHA.119.012239

Ejemplares similares

SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
por: Lam, Carolyn S. P., et al.
Publicado: (2019)

Maternal Heart Failure
por: Bright, Rachel A., et al.
Publicado: (2021)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Role of Volume Redistribution in the Congestion of Heart Failure
por: Fudim, Marat, et al.
Publicado: (2017)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2021)

Postdischarge Environment Following Heart Failure Hospitalization: Expanding the View of Hospital Readmission
por: Hersh, Andrew M., et al.
Publicado: (2013)

Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure
por: Griffin, Jan M., et al.
Publicado: (2020)

Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
por: Gronda, Edoardo, et al.
Publicado: (2020)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
por: Sikking, Maurits A., et al.
Publicado: (2023)

Fluid Volume Homeostasis in Heart Failure: A Tale of 2 Circulations
por: Miller, Wayne L.
Publicado: (2022)

Small‐Vessel Disease in the Heart and Brain: Current Knowledge, Unmet Therapeutic Need, and Future Directions
por: Berry, Colin, et al.
Publicado: (2019)

Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials
por: McCullough, Peter A., et al.
Publicado: (2022)

The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
por: Greene, Stephen J., et al.
Publicado: (2013)

Neurohormonal Regulation of I(Ks) in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death
por: Shugg, Tyler, et al.
Publicado: (2020)

All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart
por: Li, Junlang, et al.
Publicado: (2021)

Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats
por: Smith, Alex N., et al.
Publicado: (2022)

Molecular, Cellular, and Clinical Evidence That Sodium‐Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure
por: Packer, Milton
Publicado: (2020)

Gene Therapy to Treat Cardiovascular Disease
por: Wolfram, Julie A., et al.
Publicado: (2013)

Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?
por: Lip, Gregory Y. H., et al.
Publicado: (2014)

Tuberculosis and the Heart
por: López‐López, José Patricio, et al.
Publicado: (2021)

Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover
por: Martin, Thomas G., et al.
Publicado: (2021)

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
por: Spinthakis, Nikolaos, et al.
Publicado: (2018)

Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future
por: Chowdhury, Devyani, et al.
Publicado: (2021)

Cannabinoids, the Heart of the Matter
por: Alfulaij, Naghum, et al.
Publicado: (2018)

Epigenetics in Congenital Heart Disease
por: Wang, Guanglei, et al.
Publicado: (2022)

Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis
por: Addison, Daniel, et al.
Publicado: (2021)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Current Status of Prospective Drug Utilization Review
por: Fulda, Thomas R., et al.
Publicado: (2004)

The Advancing Field of Cell‐Based Therapy: Insights and Lessons From Clinical Trials
por: Telukuntla, Kartik S., et al.
Publicado: (2013)

Atrioventricular Valve Regurgitation in Single Ventricle Heart Disease: A Common Problem Associated With Progressive Deterioration and Mortality
por: Tseng, Stephanie Y., et al.
Publicado: (2020)

Challenges of Ascertaining National Trends in the Incidence of Coronary Heart Disease in the United States
por: Ford, Earl S., et al.
Publicado: (2014)

Critical Limb Ischemia: Current Trends and Future Directions
por: Teraa, Martin, et al.
Publicado: (2016)

Arrhythmias After Heart Transplantation: Mechanisms and Management
por: Thajudeen, Anees, et al.
Publicado: (2012)

Pregnancy Complicated by Valvular Heart Disease: An Update
por: Nanna, Michael, et al.
Publicado: (2014)

Degeneration of Bioprosthetic Heart Valves: Update 2020
por: Kostyunin, Alexander E., et al.
Publicado: (2020)

Stroke–Heart Syndrome: Recent Advances and Challenges
por: Scheitz, Jan F., et al.
Publicado: (2022)

Psychiatric and Psychological Interventions for Depression in Patients With Heart Disease: A Scoping Review
por: Zambrano, Juliana, et al.
Publicado: (2020)

Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter‐Defibrillator Use
por: Merchant, Faisal M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c6t35v2r1msm2g72q00s1cgcl3